Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Guttman

Showing results (271-280 of 387) with videos related to

Pageof 39
Sort By:
The Journal of Allergy and Clinical Immunology|July 15, 2023
Oral difelikefalin reduces moderate to severe pruritus and expression of pruritic and inflammatory biomarkers in subjects with atopic dermatitisEmma Guttman-Yassky, Paola Facheris, Joel Correa Da Rosa, et al.
The Journal of Allergy and Clinical Immunology|August 7, 2016
Cellular and molecular immunologic mechanisms in patients with atopic dermatitisThomas Werfel, Jean-Pierre Allam, Tilo Biedermann, et al.
Archives of Dermatological Research|March 13, 2022
Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV-VIHee J Kim, Ester Del Duca, Ana B Pavel, et al.
Frontiers in Immunology|August 27, 2025
Unravelling the transcriptomic landscape of primary lymphocytic scarring alopecias: systematic review and meta-analysisIrene Rivera-Ruiz, Benjamin Ungar, Viviana Dávila-Flores, et al.
The Journal of Allergy and Clinical Immunology|August 29, 2015
Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewingMayte Suárez-Fariñas, Benjamin Ungar, Shinji Noda, et al.
The Journal of Dermatology|September 27, 2024
Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalisNatasha Mesinkovska, Brett King, Xingqi Zhang, et al.
JAMA Dermatology|July 5, 2018
Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic DermatitisEric L Simpson, Emma Guttman-Yassky, David J Margolis, et al.
The Journal of Allergy and Clinical Immunology|January 16, 2021
The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adultsYael Renert-Yuval, Ester Del Duca, Ana B Pavel, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 1, 2023
Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: Results from a phase 2b, randomized, controlled trialEmma Guttman-Yassky, Jonathan I Silverberg, Diamant Thaçi, et al.
The Journal of Allergy and Clinical Immunology|December 22, 2018
Blood endotyping distinguishes the profile of vitiligo from that of other inflammatory and autoimmune skin diseasesTali Czarnowicki, Helen He, Alexandra Leonard, et al.
Pageof 39

Showing results (271-280 of 387) with videos related to

Sort By:
Pageof 39
The Journal of Allergy and Clinical Immunology|July 15, 2023
Oral difelikefalin reduces moderate to severe pruritus and expression of pruritic and inflammatory biomarkers in subjects with atopic dermatitisEmma Guttman-Yassky, Paola Facheris, Joel Correa Da Rosa, et al.
The Journal of Allergy and Clinical Immunology|August 7, 2016
Cellular and molecular immunologic mechanisms in patients with atopic dermatitisThomas Werfel, Jean-Pierre Allam, Tilo Biedermann, et al.
Archives of Dermatological Research|March 13, 2022
Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV-VIHee J Kim, Ester Del Duca, Ana B Pavel, et al.
Frontiers in Immunology|August 27, 2025
Unravelling the transcriptomic landscape of primary lymphocytic scarring alopecias: systematic review and meta-analysisIrene Rivera-Ruiz, Benjamin Ungar, Viviana Dávila-Flores, et al.
The Journal of Allergy and Clinical Immunology|August 29, 2015
Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewingMayte Suárez-Fariñas, Benjamin Ungar, Shinji Noda, et al.
The Journal of Dermatology|September 27, 2024
Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalisNatasha Mesinkovska, Brett King, Xingqi Zhang, et al.
JAMA Dermatology|July 5, 2018
Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic DermatitisEric L Simpson, Emma Guttman-Yassky, David J Margolis, et al.
The Journal of Allergy and Clinical Immunology|January 16, 2021
The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adultsYael Renert-Yuval, Ester Del Duca, Ana B Pavel, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 1, 2023
Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: Results from a phase 2b, randomized, controlled trialEmma Guttman-Yassky, Jonathan I Silverberg, Diamant Thaçi, et al.
The Journal of Allergy and Clinical Immunology|December 22, 2018
Blood endotyping distinguishes the profile of vitiligo from that of other inflammatory and autoimmune skin diseasesTali Czarnowicki, Helen He, Alexandra Leonard, et al.
Pageof 39